IMMEDIATE RELEASE
24 September
2024
A.G. BARR
p.l.c.
("A.G.
BARR")
A.G.
BARR p.l.c., the branded multi-beverage business with a portfolio
of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and
Boost.
INTERIM RESULTS FOR THE 26
WEEKS ENDED 27 JULY 2024
Strong H1 growth in revenue
and operating profit, with operating margin expansion, underpins
delivery of full year expectations
Financial summary
|
26 wks to 27 July
2024
|
|
26 wks to 30 July
2023
|
Change
|
Revenue
|
£221.3m
|
|
£210.4m
|
5.2%
|
Profit before tax
(adjusted)*
|
£29.3m
|
|
£27.0m
|
8.5%
|
Operating margin
(adjusted)*
|
13.0%
|
|
12.5%
|
50
bps
|
Profit before tax
|
£24.9m
|
|
£27.8m
|
(10.4%)
|
Basic EPS
|
16.88p
|
|
18.87p
|
(10.5%)
|
Basic EPS (adjusted)*
|
19.86p
|
|
18.15p
|
9.4%
|
Interim dividend per
share
|
3.10p
|
|
2.65p
|
17.0%
|
Net cash at bank*
|
£43.7m
|
|
£47.3m
|
(7.6%)
|
* Items marked with an asterisk are non-GAAP measures.
Definitions and relevant reconciliations are provided at the
end of this announcement
Highlights
â—‹
Total revenue growth of 5.2%, driven by Soft
Drinks up 7.0%, with Rubicon and IRN-BRU delivering both volume and
price gains
â—‹
A strong H1 profit performance from successfully
executing a clear and consistent strategy. Profit before tax
(adjusted)* up 8.5%
â—‹
Profit before tax of £24.9m is after £4.4m of
one-off costs related to the closure of Barr Direct and the
integration of Boost
â—‹
Operating margin (adjusted)* up 50 bps
demonstrating further progress with the margin rebuild programme,
with continued benefit anticipated in H2
â—‹
Net cash at bank* of £43.7m, down from £47.3m due
to successful acquisition of Rio in October 23, along with
significant availability on committed debt facilities to support
future growth
â—‹
Interim dividend of 3.10 pence per share
representing an increase on the prior year of 17.0%
Euan Sutherland, Chief Executive, commented:
"My first few months with the
business has further cemented my view that AG Barr is an excellent
business with exciting, tangible and deliverable growth
opportunities. I am pleased to report a strong set of first
half results. The business has delivered both revenue and profit
growth as well as good progress on our key strategic margin rebuild
programme.
We continue to invest in our
supply chain to build the capacity to support our growth plans and
manufacture more volume in-house. This will deliver tangible
benefits including enhanced margin and improved service
resilience.
We anticipate a strong H2
performance from our four core brands - IRN-BRU, Rubicon, Boost and
FUNKIN - in particular, with current trading momentum underpinned
by further marketing and innovation activities.
Guidance on 2024/25 revenue and
operating margin is unchanged. We remain confident of
continued, sustainable growth over the long term, in line with our
strategic ambitions."
For more information, please
contact:
A.G. BARR 0330 390
3900
Instinctif Partners
020 7457 2020
Euan Sutherland, Chief
Executive
Justine Warren
Stuart Lorimer, Finance
Director
Matthew Smallwood
_______________________________________________________________________________
Interim statement
We are pleased to report a strong
H1 performance through execution of our clear and consistent growth
strategy of building brands that people love.
Revenue increased 5.2% to £221.3m
and operating margin (adjusted)* improved by 50 bps to 13.0%.
This delivered profit before tax (adjusted)* growth of 8.5% to
£29.3m.
Particularly pleasing was the
performance of our Soft Drinks business where revenue increased
7.0%, driven by both volume and price. Rubicon was the stand
out performer, delivering double digit growth in both volume and
value.
Profit before tax of £24.9m
included a non-recurring (£4.4m) adjusting item related to the
business change projects involving the closure of Barr Direct and
the integration of the Boost business.
These key projects progressed to
plan in H1. The Barr Direct route to market closed at the end
of June with no impact to customer service. Symbol and
Independent retailers are now fully serviced through the wholesale
route to market, supported by a larger in-house Field Sales
team. The integration of the Boost business, acquired in
2022, is on track and will be completed during H2. Our
expectation of the payback from these two projects remains less
than 2 years. Manufacturing synergies continue to be realised
as production is insourced in line with our
plan.
Market context
Soft drinks:
The UK soft drinks market was up
2.0% versus the same period in the prior year. Growth was
price led with volumes marginally down (0.4%), partly as a
consequence of the disappointing early summer weather. Whilst
value was up, the level of price inflation in the market has
reduced significantly versus the peak in 2023. Overall, our
performance was ahead of the market across both volume and value,
with growth primarily arising in segments not measured by market
analytic data.
(Source : Circana data for the 26
weeks to 27 July 2024)
Cocktails:
Ready to drink (RTD) cocktails in
the take home market grew 9.1%, well ahead of the wider pre-mixed
alcoholic drinks market growth rate of 2.7%. FUNKIN's growth
was ahead of both market segments and it remains the number one
brand in the RTD cocktail market.
As has been widely documented, the
UK on-trade market continued to experience challenging trading
conditions during the period. The value of cocktails in the
on-trade declined by (1.3%) in the year to March 2024 driven
primarily by a (1.9%) reduction in the number of outlets.
Cocktails performed relatively favourably within this wider trend,
marginally growing volume share. Whilst we expect on-trade
cocktail consumption to return to growth in the longer term, this
may take some time given current economic and consumer
trends.
(Source: Nielsen pre-mixed
alcoholic drinks total coverage YTD 13/07/2024; CGA Q1
2024)
Business
performance
Overall revenue growth of 5.2%
driven by Soft drinks performance.
|
Revenue
(£m)
|
Change
vs
H1
2023/24 (%)
|
Soft drinks
|
£194.6m
|
7.0%
|
Cocktail solutions
(FUNKIN)
|
£21.1m
|
(9.4%)
|
Other (MOMA)
|
£5.6m
|
7.7%
|
7.0% growth in Soft Drinks revenue
was led by Rubicon, which continued to grow ahead of the market
through distribution gains and an increase in marketing
investment. Revenue from IRN-BRU was up through a combination
of volume and value growth, with a highly effective Euros marketing
campaign and continued market share gains in England. The
focus for Boost this year is on margin improvement, including
profit recovery and insourcing of production. This is progressing
in line with plan. Our soft drinks business carried good
momentum into H2 and we expect further growth in the second half
supported by our promotional and marketing investment
plans.
FUNKIN experienced a challenging
H1 with revenue down (9.4%). The key driver of this decline
was on-going weak consumer demand in the on-trade channel where
late night venues remained particularly affected. More
positively, the FUNKIN ready-to-drink (RTD) business has continued
to grow at pace in the strategic growth channel of retail despite
revenue in H1 being impacted by a short term issue with third party
can production which impacted sales to retailers but is now
resolved. With a more resilient supply chain now in place and
an exciting innovation pipeline we expect FUNKIN to perform
positively in H2.
MOMA maintained its growth in H1
with new distribution gains. We expect MOMA's growth to
accelerate in H2 through further range development.
Cash flow and balance sheet
Net cash from operating activities
of £13.0m was £2.1m below the prior year (2023/24 H1:
£15.1m). This was primarily driven by the non-recurring costs
associated with the business change projects.
We have managed working capital
effectively across H1. We collected cash in a timely manner
from our customers and had no significant unrecoverable debt during
the period. Inventory levels have generally been good albeit
we experienced a small number of specific issues with third party
suppliers which temporarily reduced inventory below desired levels
and are now resolved.
Capital expenditure* in H1 was
£7.4m (2023/24 H1: £6.5m). As in the prior year, our
plan sees higher capital expenditure expected in the second half of
the year due to the timing of specific activities. During H1
the key project completed was the installation and commissioning of
a new small PET line in Cumbernauld, which provides increased
manufacturing capability and resilience for the long term.
The Cumbernauld factory asset refresh programme remains on track,
and is expected to be completed by January 2026. Full year
capital expenditure* in the current year is estimated at c.£20m
(2023/24: £17.8m), with H2 expenditure concentrated on
investment in Cumbernauld and Milton Keynes manufacturing
lines.
The business closed the period
with net cash at bank* of £43.7m. This was £3.6m lower than
the Interim reporting date in the prior year, principally owing to
the £12.3m cash outflow in acquiring Rio in October 2023. The
closing net cash at bank* balance was £9.9m less than the period
opening position (£53.6m) due to the normal funding of dividend,
tax and capital expenditure, alongside the seasonal demands for
higher working capital during the summer trading period. We
expect our cash balance to increase in H2 as it has
historically.
Board
As previously communicated, after
20 years, Jonathan Kemp stepped down from the Board in May and will
retire from his position as Commercial Director at the end of
September 2024. Jonathan will remain with the company until
September 2025 to lead a number of projects and support a smooth
transition.
We are pleased to announce the
appointment of Dino Labbate. Dino joins in January 2025 from
Britvic, in a newly created, broader role of MD A.G. BARR,
reporting to the CEO.
The transition of CEO is now
complete and has been executed successfully without any disruption
to the business. Looking forward, the senior leadership team
is fully focused on delivering the business' strategy and
accelerating its growth trajectory.
Dividend
The Board has declared an interim
dividend for the 26 weeks ended 27 July 2024 of 3.10 pence per
share (2023/24: 2.65 pence) payable on 1 November 2024 to
shareholders on the register on 4 October 2024. This is in
line with our policy of the interim dividend being 25% of the prior
final year dividend.
Outlook
The positive H1 performance was in
line with our expectations and we have ambitious plans for H2 and
beyond, which are consistent with our long term growth
strategy. We will continue to invest behind our brands to
drive revenue growth, and continue to progress our strategic
project agenda to deliver margin improvement and strengthen our
supply base. We remain conscious of the current pressure on
consumers and will be responsive to changes in the dynamic markets
in which we operate. We are confident that, assuming a
reasonably settled external environment, the execution of our plans
will result in a strong H2 and the delivery of a full year
performance in line with current market expectations**.
Mark
Allen
Euan Sutherland
Chairman
Chief Executive
** Analyst consensus:
FY24/25 Net Revenue £421.5m, PBT £57.2m (FY23/24 PBT
£50.5m)
Consolidated Condensed Income Statement
|
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
Six months ended 27 July
2024
|
|
Six
months ended 30 July 2023
|
|
Year
ended 28 January 2024
|
|
Note
|
£m
|
|
£m
|
|
£m
|
Revenue
|
6
|
221.3
|
|
210.4
|
|
400.0
|
Cost of sales
|
(132.2)
|
|
(131.0)
|
|
(245.8)
|
Gross profit
|
6
|
89.1
|
|
79.4
|
|
154.2
|
Operating expenses
|
(64.8)
|
|
(52.2)
|
|
(104.1)
|
Operating profit
|
8
|
24.3
|
|
27.2
|
|
50.1
|
Finance income
|
9
|
0.8
|
|
0.7
|
|
1.4
|
Finance costs
|
9
|
(0.2)
|
|
(0.1)
|
|
(0.2)
|
Profit before tax
|
|
24.9
|
|
27.8
|
|
51.3
|
Tax on profit
|
10
|
(6.2)
|
|
(6.8)
|
|
(12.8)
|
Profit attributable to equity
holders
|
18.7
|
|
21.0
|
|
38.5
|
Earnings per share (pence)
|
|
|
|
|
Basic earnings per share
|
11
|
16.88
|
|
18.87
|
|
34.59
|
Diluted earnings per
share
|
11
|
16.72
|
|
18.67
|
|
34.24
|
|
|
|
|
|
|
| |
Consolidated Condensed Statement of Financial
Position
|
|
|
Unaudited
|
Unaudited
|
Audited
|
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
Note
|
£m
|
£m
|
£m
|
Non-current assets
|
Intangible assets
|
|
129.9
|
115.6
|
130.4
|
Property, plant and
equipment
|
|
107.8
|
102.2
|
109.0
|
Right-of-use assets
|
|
4.6
|
5.2
|
5.2
|
Retirement benefit
surplus
|
17
|
6.2
|
3.2
|
3.2
|
|
|
248.5
|
226.2
|
247.8
|
Current assets
|
|
|
|
|
Inventories
|
|
35.6
|
36.0
|
36.5
|
Trade and other
receivables
|
|
94.1
|
93.9
|
63.8
|
Assets classified as held for
sale
|
13
|
2.1
|
-
|
-
|
Current tax asset
|
|
0.2
|
-
|
-
|
Short-term investments
|
|
32.5
|
-
|
20.0
|
Cash and cash
equivalents
|
|
17.3
|
47.3
|
33.6
|
|
|
181.8
|
177.2
|
153.9
|
Total assets
|
|
430.3
|
403.4
|
401.7
|
Current liabilities
|
|
|
|
|
Loans and other
borrowings
|
15
|
6.1
|
-
|
-
|
Trade and other payables
|
|
86.9
|
90.7
|
70.3
|
Derivative financial
instruments
|
14
|
0.5
|
0.3
|
0.3
|
Lease liabilities
|
14
|
1.7
|
1.6
|
1.8
|
Provisions
|
16
|
2.0
|
0.5
|
0.5
|
Current tax liabilities
|
|
-
|
0.9
|
0.7
|
|
|
97.2
|
94.0
|
73.6
|
Non-current liabilities
|
|
|
|
|
Deferred tax liabilities
|
|
33.0
|
28.8
|
32.3
|
Lease liabilities
|
14
|
2.6
|
3.2
|
3.1
|
Derivative financial
instruments
|
14
|
0.1
|
-
|
-
|
|
|
35.7
|
32.0
|
35.4
|
Capital and reserves
|
Share capital
|
|
4.7
|
4.7
|
4.7
|
Share premium account
|
|
0.9
|
0.9
|
0.9
|
Share options reserve
|
|
3.1
|
4.0
|
4.0
|
Other reserves
|
|
(0.5)
|
(0.1)
|
(0.1)
|
Retained earnings
|
|
289.2
|
267.9
|
283.2
|
|
|
297.4
|
277.4
|
292.7
|
Total equity and liabilities
|
|
430.3
|
403.4
|
401.7
|
Consolidated Condensed Statement of Comprehensive
Income
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
£m
|
£m
|
£m
|
Profit for the period
|
18.7
|
21.0
|
38.5
|
Other comprehensive (expense)/income
|
|
|
|
Items that will not be reclassified to profit or
loss
|
|
|
|
Remeasurements on defined benefit
pension plans (Note 17)
|
-
|
0.7
|
0.7
|
Deferred tax movements on items
above
|
-
|
(0.2)
|
(0.2)
|
Items that will be or have been reclassified to profit or
loss
|
|
|
|
Loss arising on cash flow hedges
during the period
|
(0.6)
|
(0.3)
|
(0.3)
|
Deferred tax movements on items
above
|
0.2
|
0.1
|
0.1
|
Other comprehensive (expense)/income for the period, net of
tax
|
(0.4)
|
0.3
|
0.3
|
Total comprehensive income attributable to equity holders of
the parent
|
18.3
|
21.3
|
38.8
|
Consolidated Condensed Statement of Changes in Equity
(Unaudited)
|
|
Share
capital
|
Share premium
account
|
Share options
reserve
|
Other
reserves
|
Retained
earnings
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
At
28 January 2024
|
4.7
|
0.9
|
4.0
|
(0.1)
|
283.2
|
292.7
|
Profit for the period
|
-
|
-
|
-
|
-
|
18.7
|
18.7
|
Other comprehensive
expense
|
-
|
-
|
-
|
(0.4)
|
-
|
(0.4)
|
Total comprehensive
(expense)/income for the period
|
-
|
-
|
-
|
(0.4)
|
18.7
|
18.3
|
Company shares purchased for use by
employee benefit trusts
|
-
|
-
|
-
|
-
|
(1.9)
|
(1.9)
|
Proceeds on disposal of shares by
employee benefit trusts
|
-
|
-
|
-
|
-
|
0.7
|
0.7
|
Recognition of share-based payment
costs
|
-
|
-
|
1.4
|
-
|
-
|
1.4
|
Transfer of reserve on share
award
|
-
|
-
|
(2.3)
|
-
|
2.3
|
-
|
Dividends paid
|
-
|
-
|
-
|
-
|
(13.8)
|
(13.8)
|
At
27 July 2024
|
4.7
|
0.9
|
3.1
|
(0.5)
|
289.2
|
297.4
|
|
Share
capital
|
Share premium
account
|
Share options
reserve
|
Other
reserves
|
Retained
earnings
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
At 29 January 2023
|
4.7
|
0.9
|
3.4
|
0.1
|
259.7
|
268.8
|
Profit for the period
|
-
|
-
|
-
|
-
|
21.0
|
21.0
|
Other comprehensive
(expense)/income
|
-
|
-
|
-
|
(0.2)
|
0.5
|
0.3
|
Total comprehensive
(expense)/income for the period
|
-
|
-
|
-
|
(0.2)
|
21.5
|
21.3
|
Company shares purchased for use by
employee benefit trusts
|
-
|
-
|
-
|
-
|
(2.6)
|
(2.6)
|
Proceeds on disposal of shares by
employee benefit trusts
|
-
|
-
|
-
|
-
|
0.8
|
0.8
|
Recognition of share-based payment
costs
|
-
|
-
|
1.0
|
-
|
-
|
1.0
|
Transfer of reserve on share
award
|
-
|
-
|
(0.3)
|
-
|
0.3
|
-
|
Deferred tax on items taken direct
to reserves
|
-
|
-
|
(0.1)
|
-
|
-
|
(0.1)
|
Dividends paid
|
-
|
-
|
-
|
-
|
(11.8)
|
(11.8)
|
At 30 July 2023
|
4.7
|
0.9
|
4.0
|
(0.1)
|
267.9
|
277.4
|
Consolidated Condensed Statement of Changes in Equity
(Audited)
|
|
Share
capital
|
Share
premium account
|
Share
options reserve
|
Other
reserves
|
Retained
earnings
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
At 29 January 2023
|
4.7
|
0.9
|
3.4
|
0.1
|
259.7
|
268.8
|
|
|
|
|
|
|
|
Profit for the year
|
-
|
-
|
-
|
-
|
38.5
|
38.5
|
Other comprehensive
(expense)/income
|
-
|
-
|
-
|
(0.2)
|
0.5
|
0.3
|
Total comprehensive
(expense)/income for the year
|
-
|
-
|
-
|
(0.2)
|
39.0
|
38.8
|
Company shares purchased for use by
employee benefit trusts
|
-
|
-
|
-
|
-
|
(3.6)
|
(3.6)
|
Proceeds on disposal of shares by
employee benefit trusts
|
-
|
-
|
-
|
-
|
1.3
|
1.3
|
Recognition of share-based payment
costs
|
-
|
-
|
2.1
|
-
|
-
|
2.1
|
Transfer of reserve on share
award
|
-
|
-
|
(1.6)
|
-
|
1.5
|
(0.1)
|
Deferred tax on items taken direct
to reserves
|
-
|
-
|
0.1
|
-
|
-
|
0.1
|
Dividends paid
|
-
|
-
|
-
|
-
|
(14.7)
|
(14.7)
|
At 28 January 2024
|
4.7
|
0.9
|
4.0
|
(0.1)
|
283.2
|
292.7
|
Consolidated Condensed Cash Flow Statement
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
£m
|
£m
|
£m
|
Operating activities
|
Profit for the period before
tax
|
24.9
|
27.8
|
51.3
|
Adjustments for:
|
Interest receivable
|
(0.8)
|
(0.7)
|
(1.4)
|
Interest payable
|
0.2
|
0.1
|
0.2
|
Impairment of investment in
associate
|
-
|
0.7
|
0.7
|
Write off of loans and
receivables
|
-
|
1.5
|
1.5
|
Contingent consideration
|
-
|
(0.8)
|
(0.8)
|
Depreciation of property, plant and
equipment
|
5.8
|
5.4
|
11.2
|
Amortisation of intangible
assets
|
0.5
|
0.6
|
1.1
|
Share-based payment
costs
|
1.4
|
1.0
|
2.1
|
Impairment of assets classified as
held for sale
|
1.1
|
-
|
-
|
(Gain)/loss on sale of property,
plant and equipment
|
(0.1)
|
0.1
|
(0.5)
|
Operating cash flows before movements in working
capital
|
33.0
|
35.7
|
65.4
|
Decrease/(increase) in
inventories
|
0.9
|
(1.3)
|
(1.8)
|
Increase in receivables
|
(30.3)
|
(33.5)
|
(3.4)
|
Increase in payables
|
18.5
|
20.4
|
-
|
Difference between employer pension
contributions and amounts recognised in the income
statement
|
(2.9)
|
-
|
-
|
Cash generated by operations
|
19.2
|
21.3
|
60.2
|
Tax paid
|
(6.2)
|
(6.2)
|
(11.7)
|
Net cash from operating activities
|
13.0
|
15.1
|
48.5
|
Investing activities
|
|
|
|
Acquisition of
subsidiary
|
-
|
-
|
(12.3)
|
Purchase of property, plant and
equipment
|
(7.4)
|
(6.5)
|
(17.8)
|
Proceeds on sale of property, plant
and equipment
|
0.2
|
-
|
0.6
|
Funds placed on fixed term
deposit
|
(37.5)
|
(25.0)
|
(20.0)
|
Funds returned from fixed term
deposit
|
25.0
|
65.0
|
40.0
|
Interest received
|
0.5
|
1.1
|
1.4
|
Net cash used in investing activities
|
(19.2)
|
34.6
|
(8.1)
|
Financing activities
|
|
|
|
Loans made
|
-
|
5.0
|
5.0
|
Loans repaid
|
-
|
(5.7)
|
(5.7)
|
Lease payments
|
(1.1)
|
(1.0)
|
(1.9)
|
Purchase of Company shares by
employee benefit trusts
|
(1.9)
|
(2.6)
|
(3.6)
|
Proceeds from disposal of Company
shares by employee benefit trusts
|
0.7
|
0.8
|
1.3
|
Dividends paid
|
(13.8)
|
(11.8)
|
(14.7)
|
Interest paid
|
(0.1)
|
-
|
(0.1)
|
Net cash used in financing activities
|
(16.2)
|
(15.3)
|
(19.7)
|
Net (decrease)/increase in cash and cash
equivalents
|
(22.4)
|
34.4
|
20.7
|
Cash and cash equivalents at
beginning of period
|
33.6
|
12.9
|
12.9
|
Cash and cash equivalents at end of period
|
11.2
|
47.3
|
33.6
|
Cash and cash equivalents per the
cash flow statement comprises cash and cash equivalents per the
statement of financial position of £17.3m, net of bank overdrafts
of £6.1m for the period ended 27 July 2024.
|
Notes to the Consolidated Condensed Financial
Statements
|
|
|
1.
General information
A.G. BARR p.l.c. (the "Company") and its subsidiaries (together the
"Group") manufacture, distribute and sell a range of beverages. The
Group has manufacturing sites in the UK and sells mainly to
customers in the UK with some international sales.
The Company is a public limited company, which is listed on the
London Stock Exchange and incorporated and domiciled in Scotland.
The address of its registered office is Westfield House, 4 Mollins
Road, Cumbernauld, G68 9HD.
This consolidated condensed interim financial information does not
comprise statutory accounts within the meaning of section 434 of
the Companies Act 2006. Statutory accounts for the year ended 28
January 2024 were approved by the Board of Directors on 26 March
2024 and delivered to the Registrar of Companies. The comparative
figures for the financial year ended 28 January 2024 are an extract
of the Company's statutory accounts for that year. The report of
the auditor on those accounts was unqualified, did not contain an
emphasis of matter paragraph and did not contain any statement
under section 498 (2) or (3) of the Companies Act 2006.
This consolidated condensed interim financial information is
unaudited but has been reviewed by the Company's Auditor.
2. Basis of preparation
This consolidated condensed interim financial information for the
26 weeks ended 27 July 2024 has been prepared in accordance with
UK-adopted International Accounting Standard 34, 'Interim Financial
Reporting' and the Disclosure Guidance and Transparency Rules
sourcebook of the United Kingdom's Financial Conduct Authority. The
interim report does not include all of the notes of the type
normally included in an annual financial report. Accordingly, this
report is to be read in conjunction with the annual report for the
year ended 28 January 2024, which has been prepared in accordance
with UK-adopted international accounting standards and with the
requirements of the Companies Act 2006.
Going concern basis
The directors have adopted the going concern basis in preparing
these accounts after assessing the principal risks.
There has been no further update to the assessment undertaken in
the year ended 28 January 2024, which remains valid. This reviewed
a number of severe but plausible downside scenarios that could
impact the business (both individually and cumulatively) over the
period until January 2027. These scenarios include a major brand
issue which impacts reputation and consumer purchasing, a cyber
attack and a global pandemic. In each scenario the Group continues
to be cash generative throughout the forecast horizon, resulting in
our liquidity headroom being maintained.
Our experience through the Covid-19 pandemic has given us
confidence that the Group can remain profitable and cash generative
through prolonged disruption.
The most significant potential financial impact would be due to a
significant reduction in sales. The revenue and operational
leverage impact of such a volume loss would have a negative impact
on Group profitability, however the scenario modelling would
indicate that the Group would remain profitable over the next 12
months and we would anticipate a recovery in the following
years.
The Group has £20m of committed, unutilised revolving credit
facilities providing the business with a secure funding platform.
The facility expires in February 2026. In the period, the Group has
put in place a £15m overdraft facility to support intra-month
working capital requirements and maximise cash deposit interest.
Throughout these severe but plausible downside scenarios, the Group
continues to have significant liquidity headroom on existing
facilities and against the revolving credit facilities financial
covenants.
The directors believe that the Group is well placed to manage its
financing and other business risks satisfactorily, and have a
reasonable expectation that the Group and parent Company will have
adequate resources to continue in operation for at least 12 months
from the signing date of these condensed consolidated financial
statements. They therefore consider it appropriate to adopt the
going concern basis of accounting in preparing these financial
statements.
|
|
3.
Accounting policies
|
New standards and interpretations applied for the first
time
|
In the current year, the Group has
applied a number of amendments to IFRS Accounting Standards issued
by the International Accounting Standards Board (IASB) and endorsed
for use in the UK which are mandatorily effective for accounting
periods beginning on or after 29 January 2024. Apart from those
changes to accounting policies noted below, the accounting policies
applied in these condensed interim financial statements are the
same as those applied in the most recent annual report for the year
ended 28 January 2024. There has been no material impact on the
amounts reported or disclosures required in these condensed interim
financial statements.
|
- Classification of Liabilities as
Current or Non-current and Non-current liabilities with covenants -
Amendments to IAS 1
|
- Lease liability in sale and
leaseback - Amendments to IFRS 16
|
- Supplier Finance Arrangements -
Amendments to IAS 7 and IFRS 7
|
Assets classified as held for sale
|
Assets classified as held for sale
are measured at the lower of the carrying amount and fair value
less costs to sell where the assets meet the 'held for sale'
criteria within IFRS 5. Depreciation on these assets ceases and
they are presented within current assets in the balance
sheet.
|
4.
Principal risks and uncertainties
|
The directors consider that the
following principal risks and uncertainties could have a material
impact on the Group's performance in the balance of the financial
year. Further detail can be found on pages 48 - 55 of the Group's
annual financial statements as at 28 January 2024, which are
available on our website, www.agbarr.co.uk.
|
- Changes in consumer preferences,
perception or purchasing behaviour
|
- Consumer rejection of
reformulated products
|
- Loss of product
integrity
|
- Loss of continuity of supply of
major raw materials
|
- Adverse publicity in relation to
the soft drinks industry, the Group or its brands
|
- Government intervention on
climate change and environmental issues e.g. packaging
waste
|
- Failure to maintain customer
relationships or take account of changing market
dynamics
|
- Inability to protect the Group's
intellectual property rights
|
- Failure of the Group's
operational infrastructure
|
- Failure of critical IT systems or
a breach of cyber security
|
- Financial risks
|
- Environmental Social and
Governance (ESG) risks
|
The Group has reviewed its exposure
to climate-related and other emerging business risks but has not
identified any specific risks that would impact the financial
performance or position of the Group at 27 July 2024.
|
5.
Financial risk management and financial
instruments
|
The Group's activities expose it to
a variety of financial risks: market risk (including foreign
exchange risk, cash flow and fair value interest rate risk and
price risk), credit risk and liquidity risk.
The condensed interim financial statements should be read in
conjunction with the Group's annual financial statements as at 28
January 2024 as they do not include all financial risk management
information and disclosures contained within the annual financial
statements. There have been no changes in the risk management
policies since the year end.
|
6.
Segment reporting
|
|
The Board and senior executives
have been identified as the Group's chief operating
decision-makers, who review the Group's internal reporting in order
to assess performance and allocate resources.
The performance of the operating segments is assessed by reference
to their gross profit.
|
|
Unaudited
|
|
Six months ended 27 July 2024
|
|
|
Soft drinks
|
Cocktail
solutions
|
Other
|
Total
|
£m
|
£m
|
£m
|
£m
|
Total revenue
|
194.6
|
21.1
|
5.6
|
221.3
|
Gross profit
|
79.5
|
7.8
|
1.8
|
89.1
|
Unaudited
|
|
Six months ended 30 July
2023
|
|
|
Soft
drinks
|
Cocktail
solutions
|
Other
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
Total revenue
|
181.9
|
23.3
|
5.2
|
210.4
|
Gross profit
|
69.9
|
7.9
|
1.6
|
79.4
|
Audited
|
|
Year ended 28 January
2024
|
|
|
Soft
drinks
|
Cocktail
solutions
|
Other
|
Total
|
|
£m
|
£m
|
£m
|
£m
|
Total revenue
|
346.6
|
42.9
|
10.5
|
400.0
|
Gross profit
|
135.6
|
15.4
|
3.2
|
154.2
|
|
|
|
|
| |
There are no material intersegment
sales. All revenue is in relation to product sales, which is
recognised at a point in time, upon delivery to the customer.
All of the assets and liabilities of the Group are managed on a
central basis rather than at a segment level. As a result, no
reconciliations of segment assets and liabilities to the
consolidated condensed statement of financial position has been
disclosed for any of the periods presented.
Included in revenues arising from the above segments are revenues
of approximately £39.0m which arose from sales to the Group's
largest customer. In the year ended 28 January 2024 and six months
ended 30 July 2023, revenues of approximately £68.0m and £37.5m
respectively arose from sales to the Group's largest customer. No
other single customer contributed 10 per cent or more to the
Group's revenue in the comparative period to July 2023 or January
2024.
All of the segments included within "Soft drinks" and "Cocktail
solutions" meet the aggregation criteria set out in IFRS 8
Operating Segments.
|
7.
Seasonality of operations
|
Revenues and reported profits are
affected by weather conditions, cost inflation, the timing of
marketing and promotional investment and innovation launches. Owing
to the timing of the one-off costs related to the business change
projects, reported profits for the second half of the year to 25
January 2025 are expected to be higher than those for the 26 weeks
ended 27 July 2024.
|
8.
Operating profit
|
|
|
|
The following items have been
charged/(credited) to operating profit during the
period:
|
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
£m
|
£m
|
£m
|
Business change projects
|
4.4
|
-
|
-
|
Provision for business
reorganisation
|
0.7
|
-
|
-
|
(Gain)/loss on sale of property,
plant and equipment
|
(0.1)
|
0.1
|
-
|
Included within the business change
project costs is a £1.1m impairment charge against assets
classified as held for sale (Note 13).
|
9.
Net finance costs
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
Finance income
|
£m
|
£m
|
£m
|
Interest receivable on short-term
deposits
|
0.7
|
0.6
|
1.3
|
Finance costs relating to defined
benefit pension plans
|
0.1
|
0.1
|
0.1
|
|
0.8
|
0.7
|
1.4
|
Finance costs
|
£m
|
£m
|
£m
|
Interest payable
|
0.1
|
-
|
0.1
|
Lease interest
|
0.1
|
0.1
|
0.1
|
|
0.2
|
0.1
|
0.2
|
10. Tax on profit
|
The interim period total tax charge
of £6.2m (six months ended 30 July 2023: £6.8m; year ended 28
January 2024: £12.8m) is accrued based on the estimated annual
effective tax rate of 24.9% (six months ended 30 July 2023: 24.5%;
year ended 28 January 2024: 25.0%). The effective tax rate is
calculated using the forecast year end effective corporation tax
rate and the movement in deferred tax to 27 July 2024. The
effective tax rate has remained relatively unchanged in the six
months ended 27 July 2024 compared to the year ended 28 January
2024.
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
Analysis of tax charge
|
£m
|
£m
|
£m
|
Current income tax
charge
|
5.3
|
6.4
|
11.7
|
Deferred income tax
charge
|
0.9
|
0.4
|
1.1
|
Total tax charge in the condensed income
statement
|
6.2
|
6.8
|
12.8
|
11. Earnings per share
|
Basic earnings per share has been
calculated by dividing the earnings attributable to equity holders
of the parent by the weighted average number of shares in issue
during the year, excluding shares held by the employee share scheme
trusts.
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
Profit attributable to equity
holders of the Company (£m)
|
18.7
|
21.0
|
38.5
|
Weighted average number of ordinary
shares in issue
|
110,797,643
|
111,288,517
|
111,289,068
|
Basic earnings per share (pence)
|
16.88
|
18.87
|
34.59
|
For diluted earnings per share, the
weighted average number of ordinary shares in issue is adjusted to
assume conversion of all potentially dilutive ordinary shares.
These represent share options granted to employees where the
exercise price is less than the average market price of the
Company's ordinary shares during the period. The number of shares
calculated as above is compared with the number of shares that
would have been issued assuming the exercise of the share
options.
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
Profit attributable to equity
holders of the Company (£m)
|
18.7
|
21.0
|
38.5
|
Weighted average number of ordinary
shares in issue
|
110,797,643
|
111,288,517
|
111,289,068
|
Adjustment for dilutive effect of
share options
|
1,047,922
|
1,193,573
|
1,159,537
|
Diluted weighted average number of
ordinary shares in issue
|
111,845,565
|
112,482,090
|
112,448,605
|
Diluted earnings per share (pence)
|
16.72
|
18.67
|
34.24
|
|
12. Dividends
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
per share
(p)
|
per
share (p)
|
per share
(p)
|
£m
|
£m
|
£m
|
Paid final dividend
|
12.4
|
10.60
|
10.60
|
13.8
|
11.8
|
11.8
|
Paid interim dividend
|
-
|
-
|
2.65
|
-
|
-
|
2.9
|
|
12.40
|
10.60
|
13.25
|
13.8
|
11.8
|
14.7
|
An interim dividend of 3.10 pence
per share was approved by the Board on 24 September 2024 and will
be paid on 1 November 2024 to shareholders on the register as of 4
October 2024.
|
|
13. Assets classified as held for sale
|
Unaudited
|
£m
|
Balance at 29 January 2023 and 28
January 2024
|
-
|
Net book value of assets
transferred from property, plant and equipment
|
3.2
|
Impairment charge
|
(1.1)
|
Balance at 27 July 2024
|
2.1
|
The closure of the Barr Direct
business resulted in a number of vehicles on the balance sheet with
no estimated useful life. Following an assessment of fair value
less costs to sell an impairment charge of £1.1m has been
recognised. These assets are being actively marketed and a number
have been sold since the period end.
|
14. Financial instruments
|
|
|
|
|
Current liabilities of £0.5m (at 30
July 2023 and 28 January 2024: £0.3m) relate to forward foreign
currency contracts with a maturity of less than 12 months and are
recognised at fair value through the cash flow hedge reserve,
included within other reserves.
Non-current liabilities of £0.1m (at 30 July 2023 and 28 January
2024: £nil) relate to forward foreign currency contracts with a
maturity of more than 12 months and are recognised at fair value
through the cash flow hedge reserve, included within other
reserves.
Fair value hierarchy
Fair value hierarchies 1 to 3 are based on the degree to which fair
value is observable:
Level 1: quoted prices (unadjusted) in active markets for identical
assets or liabilities
Level 2: inputs other than quoted prices included within Level 1
that are observable for the asset or liability, either directly
(i.e. as prices) or indirectly (i.e. derived from prices)
Level 3: inputs for the asset or liability that are not based on
observable market data
The fair value of financial instruments that are not traded in an
active market (for example, over-the-counter derivatives) is
determined by using valuation techniques. These valuation
techniques maximise the use of observable market data where it is
available and rely as little as possible on entity specific
estimates. The fair value of the forward foreign exchange contracts
is determined using forward exchange rates at the date of the
consolidated condensed statement of financial position, with the
resulting value discounted accordingly as relevant.
All financial instruments carried at fair value are Level 2.
Fair values of financial assets
and financial liabilities
The following table shows the carrying amounts and fair values of
financial assets and financial liabilities. It does not include
fair value information for financial assets and financial
liabilities not measured at fair value if the carrying amount is a
reasonable approximation of fair value.
|
|
Carrying
amount
|
Unaudited
|
Fair value - hedging
instruments
|
Other financial assets at
amortised cost
|
Other financial liabilities
at amortised cost
|
Total
|
At
27 July 2024
|
£m
|
£m
|
£m
|
£m
|
Financial assets - Current
|
Foreign exchange contracts used for
hedging
|
-
|
-
|
-
|
-
|
Trade receivables
|
-
|
91.2
|
-
|
91.2
|
Short-term investments
|
-
|
32.5
|
-
|
32.5
|
Cash and cash
equivalents
|
-
|
17.3
|
-
|
17.3
|
|
-
|
141.0
|
-
|
141.0
|
Financial liabilities - Non-current
|
Foreign exchange contracts used for
hedging
|
0.1
|
-
|
-
|
0.1
|
Lease liabilities
|
-
|
-
|
2.6
|
2.6
|
|
0.1
|
-
|
2.6
|
2.7
|
Financial liabilities - Current
|
Bank overdraft
|
-
|
-
|
6.1
|
6.1
|
Foreign exchange contracts used for
hedging
|
0.5
|
-
|
-
|
0.5
|
Lease liabilities
|
-
|
-
|
1.7
|
1.7
|
Accruals
|
-
|
-
|
37.0
|
37.0
|
Trade payables
|
-
|
-
|
42.6
|
42.6
|
|
0.5
|
-
|
87.4
|
87.9
|
|
|
Carrying
amount
|
Unaudited
|
Fair
value - hedging instruments
|
Other
financial assets at amortised cost
|
Other
financial liabilities at amortised cost
|
Total
|
At 30 July 2023
|
£m
|
£m
|
£m
|
£m
|
Financial assets - Current
|
Foreign exchange contracts used for
hedging
|
-
|
-
|
-
|
-
|
Trade receivables
|
-
|
93.9
|
-
|
93.9
|
Cash and cash
equivalents
|
-
|
47.3
|
-
|
47.3
|
|
-
|
141.2
|
-
|
141.2
|
Financial liabilities - Non-current
|
Lease liabilities
|
-
|
-
|
3.2
|
3.2
|
|
-
|
-
|
3.2
|
3.2
|
Financial liabilities - Current
|
Foreign exchange contracts used for
hedging
|
0.3
|
-
|
-
|
0.3
|
Lease liabilities
|
-
|
-
|
1.6
|
1.6
|
Trade payables
|
-
|
-
|
90.7
|
90.7
|
|
0.3
|
-
|
92.3
|
92.6
|
|
Carrying
amount
|
Audited
|
Fair
value - hedging instruments
|
Other
financial assets at amortised cost
|
Other
financial liabilities at amortised cost
|
Total
|
At 28 January 2024
|
£m
|
£m
|
£m
|
£m
|
Financial assets - Current
|
Trade receivables
|
-
|
59.8
|
-
|
59.8
|
Short-term investments
|
-
|
20.0
|
-
|
20.0
|
Cash and cash
equivalents
|
-
|
33.6
|
-
|
33.6
|
|
-
|
113.4
|
-
|
113.4
|
Financial liabilities - Non-current
|
Lease liabilities
|
-
|
-
|
3.1
|
3.1
|
|
-
|
-
|
3.1
|
3.1
|
Financial liabilities - Current
|
Foreign exchange contracts used for
hedging
|
0.3
|
-
|
-
|
0.3
|
Lease liabilities
|
-
|
-
|
1.8
|
1.8
|
Accruals
|
-
|
-
|
30.0
|
30.0
|
Trade payables
|
-
|
-
|
36.1
|
36.1
|
|
0.3
|
-
|
67.9
|
68.2
|
|
15. Loans and other borrowings
|
Movements in borrowings are
analysed as follows:
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
£m
|
£m
|
£m
|
Opening borrowings
balance
|
4.9
|
5.8
|
5.8
|
Net lease movements
|
(0.6)
|
(0.3)
|
(0.2)
|
Borrowings
acquired/drawn-down
|
6.1
|
5.0
|
5.0
|
Repayments of borrowings
|
-
|
(5.7)
|
(5.7)
|
Closing borrowings
balance
|
10.4
|
4.8
|
4.9
|
The reconciliation of the above
closing borrowings balance to the figures on the face of the
consolidated condensed statement of financial position is as
follows:
|
|
Unaudited
|
Unaudited
|
Audited
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
£m
|
£m
|
£m
|
Bank borrowings
|
6.1
|
-
|
-
|
Lease liabilities
|
4.3
|
4.8
|
4.9
|
Total borrowings and
loans
|
10.4
|
4.8
|
4.9
|
Disclosed as:
|
Current liabilities
|
7.8
|
1.6
|
1.8
|
Non-current liabilities
|
2.6
|
3.2
|
3.1
|
The reconciliation to net debt is
as follows:
|
|
|
|
|
Unaudited
|
Unaudited
|
Audited
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
£m
|
£m
|
£m
|
Closing borrowings
balance
|
(10.4)
|
(4.8)
|
(4.9)
|
Short-term investments
|
32.5
|
-
|
20.0
|
Cash and cash
equivalents
|
17.3
|
47.3
|
33.6
|
Net funds
|
39.4
|
42.5
|
48.7
|
In July 2024, the Group agreed a
£15m overdraft facility with the Royal Bank of Scotland. This will
support intra-month working capital requirements and maximise cash
deposit interest.
|
The drawn/undrawn facilities at 27
July 2024 are as follows:
|
|
Total
facility
|
Drawn
|
Undrawn
|
|
£m
|
£m
|
£m
|
Revolving credit facility - five
years, expires February 2026
|
20.0
|
-
|
20.0
|
Overdraft facility
|
15.0
|
6.1
|
8.9
|
|
35.0
|
6.1
|
28.9
|
|
16. Provisions
|
|
Business change
projects
|
Business
reorganisation
|
Customer related
provisions
|
Repairs/
Dilapidations
|
Total
|
Unaudited
|
£m
|
£m
|
£m
|
£m
|
£m
|
Opening provision at 29 January
2023
|
-
|
0.3
|
0.1
|
0.4
|
0.8
|
Provision utilised during the
year
|
-
|
(0.3)
|
-
|
-
|
(0.3)
|
Closing provision at 28 January
2024
|
-
|
-
|
0.1
|
0.4
|
0.5
|
Provision created during the
year
|
3.3
|
0.7
|
-
|
-
|
4.0
|
Provision utilised during the
year
|
(2.5)
|
-
|
-
|
-
|
(2.5)
|
Closing provision at 27 July 2024
|
0.8
|
0.7
|
0.1
|
0.4
|
2.0
|
The business change projects
provision relates to the costs associated with two projects.
Firstly, the closure of the Barr Direct operation and the move to
larger field sales team, supplying brands through existing
wholesale channels which completed in June. Secondly, the
integration of the Boost business into Barr Soft Drinks. This will
result in a reduction in duplicated activities and access to the
wider Barr Soft Drinks sales channels and organisation and also the
closure of the Boost Leeds office. This is expected to complete by
the end of the year ending 25 January 2025.
The business reorganisation provision relates to costs associated
with a number of smaller business reorganisations not related to
the business change projects.
The customer related provision relates to costs for chiller and
vendor disposal and the repairs and dilapidation provision relates
to costs provided to make good leased properties on
exit.
|
17. Retirement benefit obligations
|
On 1 May 2016 the A.G. BARR p.l.c.
(2008) Pension and Life Assurance Scheme was closed to future
accrual following a negotiated agreement between the Company and
the board of trustees.
The defined retirement benefit scheme had a surplus of £6.2m as at
27 July 2024 (surplus as at 30 July 2023: £3.2m; surplus as at 28
January 2024: £3.2m). The reconciliation of the closing surplus is
as follows:
|
|
Unaudited
|
Unaudited
|
Audited
|
|
Six months ended 27 July
2024
|
Six
months ended 30 July 2023
|
Year
ended 28 January 2024
|
|
£m
|
£m
|
£m
|
Opening present value of
obligation
|
(69.3)
|
(76.9)
|
(76.9)
|
Interest expense
|
(1.6)
|
(1.6)
|
(3.3)
|
Remeasurement - changes in
financial assumptions
|
(0.5)
|
6.2
|
6.7
|
Benefits paid
|
1.7
|
1.9
|
4.2
|
Closing present value of
obligation
|
(69.7)
|
(70.4)
|
(69.3)
|
Opening fair value of plan
assets
|
72.5
|
79.3
|
79.3
|
Interest income
|
1.7
|
1.7
|
3.4
|
Remeasurement - actuarial return on
assets
|
0.5
|
(5.5)
|
(6.0)
|
Employer contributions
|
2.9
|
-
|
-
|
Benefits paid
|
(1.7)
|
(1.9)
|
(4.2)
|
Closing fair value of plan
assets
|
75.9
|
73.6
|
72.5
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
£m
|
£m
|
£m
|
Present value of funded
obligations
|
(69.7)
|
(70.4)
|
(69.3)
|
Fair value of plan
assets
|
75.9
|
73.6
|
72.5
|
Surplus recognised under IAS
19
|
6.2
|
3.2
|
3.2
|
The key financial assumptions used
to value the liabilities were as follows:
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
%
|
%
|
%
|
Discount rate
|
5.1
|
5.2
|
5.0
|
Inflation assumption
|
3.2
|
3.2
|
3.1
|
|
18. Movements in own shares held by employee benefit
trusts
|
During the six months to 27 July
2024 the employee benefit trusts of the Group acquired 338,003 (six
months to 30 July 2023: 520,218; year to 28 January 2024: 732,524)
of the Company's shares. The total amount paid to acquire the
shares has been deducted from shareholders' equity and is included
within retained earnings. At 27 July 2024 the shares held by
the Company's employee benefit trusts represented 793,306 (30 July
2023: 1,187,730; 28 January 2024: 1,048,677) shares at a purchased
cost of £4.1m (30 July 2023: £6.6m; 28 January 2024: £5.4m).
593,778 (six months to 30 July 2023: 220,041; year to 28 January
2024: 571,410) shares were utilised in satisfying share options
from the Company's employee share schemes during the same period.
The related weighted average share price at the time of exercise
for the six months to 27 July 2024 was £6.00 (six months to 30 July
2023: £4.66; year to 28 January 2024: £4.78).
|
19. Contingencies and commitments
|
|
Unaudited
|
Unaudited
|
Audited
|
|
As at 27 July
2024
|
As at 30
July 2023
|
As at 28
January 2024
|
|
£m
|
£m
|
£m
|
Commitments for the acquisition of
property, plant and equipment
|
2.5
|
7.7
|
8.7
|
20. Related party transactions
|
|
|
|
There have been no related party
transactions in the first 26 weeks of the current financial year
which have materially affected the financial position or
performance of the Group.
|
RESPONSIBILITY AND CAUTIONARY STATEMENTS
|
Responsibility Statement
|
Company law requires the directors
to prepare statements for each financial year. Under that law the
directors are required to prepare group financial statements in
accordance with international accounting standards in conformity
with the requirements of the Companies Act 2006 and UK-adopted
International Financial Reporting Standards.
The directors confirm that these consolidated condensed interim
financial statements have been prepared in accordance with
International Accounting Standard 34 Interim Financial Reporting.
The interim management report includes a fair review of the
information required by DTR 4.2.7 and DTR 4.2.8, namely:
• an indication of important events that have occurred during the
first six months and their impact on the condensed set of financial
statements, and a description of the principal risks and
uncertainties for the remaining six months of the financial year;
and
• material related party transactions in the first six months and
any material changes in the related party transactions described in
the last annual report.
Cautionary Statement
This report is addressed to the shareholders of A.G. BARR p.l.c.
and has been prepared solely to provide information to them.
This report is intended to inform the shareholders of the Group's
performance during the six months to 27 July 2024. This report
contains forward-looking statements based on knowledge and
information available to the directors as at the date the report
was prepared. These statements should be treated with caution due
to the inherent uncertainties underlying any such forward-looking
information and any statements about the future outlook may be
influenced by factors that could cause actual outcomes and results
to be materially different.
The directors of A.G. BARR p.l.c. that served during the six months
to 27 July 2024 and up to the date of signing, and their respective
responsibilities, were:
Mark Allen OBE (Chair)
Roger A. White (Chief Executive) (resigned 30 April 2024)
Euan Sutherland (Chief Executive) (appointed 1 May 2024)
Stuart Lorimer (Finance Director)
Jonathan D. Kemp (Commercial Director) (resigned 31 May 2024)
Susan V. Barratt
Zoe L. Howorth
David J. Ritchie (resigned 31 May 2024)
Nicholas B.E. Wharton
Julie A. Barr
Louise H. Smalley
For and on behalf of the Board of Directors
|
|
|
Euan Sutherland
|
Stuart Lorimer
|
Chief Executive
|
Finance Director
|
24 September 2024
|
24 September 2024
|
Glossary
Non-GAAP measures
are provided because they are tracked by management to assess the
Group's operating performance and to inform financial, strategic
and operating decisions.
Adjusting items
The Group excludes adjusting items from
its non-GAAP measures because of their size, frequency and nature
to allow shareholders to understand better the elements of
financial performance in the period, so as to facilitate comparison
with prior periods and to assess trends in financial performance
more readily. These items are primarily non-operational.
Definitions of non-GAAP measures used are provided
below:
Capital expenditure is a non-GAAP measure and is defined as
the cash purchases of property, plant and equipment and is
disclosed in the consolidated condensed cash flow statement.
Adjusted profit attributable to
equity holders is a non-GAAP measure calculated as adjusted
profit attributable to equity holders.
Operating margin (adjusted)
is a non-GAAP measure calculated by dividing adjusted operating
profit by revenue.
Profit before tax
(adjusted) is a non-GAAP measure calculated as reported
profit before tax after adjusting items.
Basic EPS (adjusted) is a
non-GAAP measure calculated by dividing adjusted profit
attributable to equity holders by the weighted average number of
shares in issue.
Reconciliation of Non-GAAP measures
|
Adjusted Consolidated Income Statements
|
|
Six months ended 27 July
2024
|
|
Six
months ended 30 July 2023
|
|
Year
ended 28 January 2024
|
|
Reported
|
Business change
projects
|
Adjusted
|
|
Reported
|
Boost
earn-out accrual write back
|
Adjusted
|
|
Reported
|
Boost
earn-out accrual write back
|
Adjusted
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
Revenue
|
221.3
|
-
|
221.3
|
|
210.4
|
-
|
210.4
|
|
400.0
|
-
|
400.0
|
Cost of sales
|
(132.2)
|
-
|
(132.2)
|
|
(131.0)
|
-
|
(131.0)
|
|
(245.8)
|
-
|
(245.8)
|
Gross profit
|
89.1
|
-
|
89.1
|
|
79.4
|
-
|
79.4
|
|
154.2
|
-
|
154.2
|
Operating expenses
|
(64.8)
|
4.4
|
(60.4)
|
|
(52.2)
|
(0.8)
|
(53.0)
|
|
(104.1)
|
(0.8)
|
(104.9)
|
Operating profit
|
24.3
|
4.4
|
28.7
|
|
27.2
|
(0.8)
|
26.4
|
|
50.1
|
(0.8)
|
49.3
|
Finance income
|
0.8
|
-
|
0.8
|
|
0.7
|
-
|
0.7
|
|
1.4
|
-
|
1.4
|
Finance costs
|
(0.2)
|
-
|
(0.2)
|
|
(0.1)
|
-
|
(0.1)
|
|
(0.2)
|
-
|
(0.2)
|
Profit before tax
|
24.9
|
4.4
|
29.3
|
|
27.8
|
(0.8)
|
27.0
|
|
51.3
|
(0.8)
|
50.5
|
Tax on profit
|
(6.2)
|
(1.1)
|
(7.3)
|
|
(6.8)
|
-
|
(6.8)
|
|
(12.8)
|
-
|
(12.8)
|
Profit for the period
|
18.7
|
3.3
|
22.0
|
|
21.0
|
(0.8)
|
20.2
|
|
38.5
|
(0.8)
|
37.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusting entries:
Business change projects - the costs
associated with the business change projects involving the closure
of Barr Direct operations and the integration of the Boost
business.
Boost earn-out reversal -
certain conditions associated with the Boost earn-out were not met
and as such the earn-out was not be payable in its previous form
but was incorporated into employee reward incentives.
|
|
|
|
|
|
|
|
|
|
|
|
| |
Operating margin (adjusted)
|
Six months ended 27 July
2024
£m
|
|
Six
months ended 30 July 2023
£m
|
|
Year
ended 28 January 2024
£m
|
Revenue
|
221.3
|
|
210.4
|
|
400.0
|
Adjusted operating
profit
|
28.7
|
|
26.4
|
|
49.3
|
Operating margin (adjusted)
|
13.0%
|
|
12.5%
|
|
12.3%
|
Net cash at bank
|
£m
|
|
£m
|
|
£m
|
Cash and cash
equivalents
|
17.3
|
|
47.3
|
|
33.6
|
Short-term investments
|
32.5
|
|
-
|
|
20.0
|
Bank overdraft
|
(6.1)
|
|
-
|
|
-
|
Net cash at bank
|
43.7
|
|
47.3
|
|
53.6
|
Basic EPS (adjusted)
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted profit attributable to
equity shareholders of the Company £m
|
22.0
|
|
20.2
|
|
37.7
|
Weighted average number of ordinary
shares in issue
|
110,797,643
|
|
111,288,517
|
|
111,289,068
|
Basic EPS (adjusted)
|
19.86p
|
|
18.15p
|
|
33.88p
|
|
|
|
|
|
|
|
|
|
|
|
| |